<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="aoa" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">aoa</book-part-id>
      <title-group>
        <title>Ataxia with Oculomotor Apraxia Type 1</title>
        <alt-title alt-title-type="alt-title">Synonym: AOA1</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Coutinho</surname>
            <given-names>Paula</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <aff>Instituto de Investiga&#x000e7;&#x000e3;o e Inova&#x000e7;&#x000e3;o em Sa&#x000fa;de<break/>Centro de Gen&#x000e9;tica Preditiva e Preventiva<break/>IBMC-Instituto de Biologia Molecular e Celular, UnIGENe<break/>Universidade do Porto<break/>Porto, Portugal</aff>
          <email>coutinho.mpaula@gmail.com</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Barbot</surname>
            <given-names>Clara</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <aff>Instituto de Investiga&#x000e7;&#x000e3;o e Inova&#x000e7;&#x000e3;o em Sa&#x000fa;de<break/>Centro de Gen&#x000e9;tica Preditiva e Preventiva<break/>IBMC-Instituto de Biologia Molecular e Celular, UnIGENe<break/>Universidade do Porto<break/>Porto, Portugal</aff>
          <email>clarabarbot@gmail.com</email>
        </contrib>
      </contrib-group>
      <pub-history>
        <date date-type="created">
          <day>11</day>
          <month>6</month>
          <year>2002</year>
        </date>
        <date date-type="updated">
          <day>19</day>
          <month>3</month>
          <year>2015</year>
        </date>
        <date date-type="revised">
          <day>28</day>
          <month>1</month>
          <year>2004</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="mld" document-type="chapter">Arylsulfatase A Deficiency</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="aoa2" document-type="chapter">Ataxia with Oculomotor Apraxia Type 2</related-object>
      <abstract id="aoa.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>Ataxia with oculomotor apraxia type 1 (AOA1) is characterized by childhood onset of slowly progressive cerebellar ataxia, followed by oculomotor apraxia and a severe primary motor peripheral axonal motor neuropathy. The first manifestation is progressive gait imbalance (mean age of onset: 4.3 years; range: 2-10 years), followed by dysarthria, then upper-limb dysmetria with mild intention tremor. Oculomotor apraxia, usually noticed a few years after the onset of ataxia, progresses to external ophthalmoplegia. All affected individuals have generalized areflexia followed by a peripheral neuropathy and quadriplegia with loss of ambulation about seven to ten years after onset. Hands and feet are short and atrophic. Chorea and upper-limb dystonia are common. Intellect remains normal in some individuals; in others, different degrees of cognitive impairment have been observed.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>The diagnosis of AOA1 is based on clinical findings (including family history) and exclusion of the diagnosis of ataxia-telangiectasia. Cerebellar atrophy is visible on MRI in all affected individuals. EMG reveals axonal neuropathy in 100% of individuals with AOA1. <italic toggle="yes">APTX</italic> is the only gene known to be associated with AOA1.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> May include physical therapy, particularly for disabilities resulting from peripheral neuropathy; a wheelchair for mobility, usually by age 15-20 years; educational support for difficulties with speaking, reading, and writing.</p>
          <p><italic toggle="yes">Prevention of secondary complications:</italic> High-protein diet to prevent edema by restoring serum albumin concentration; low-cholesterol diet.</p>
          <p><italic toggle="yes">Surveillance:</italic> Routine follow up with a neurologist.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>AOA1 is inherited in an autosomal recessive manner. At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being neither affected nor a carrier. Carrier testing for at-risk family members and prenatal testing for pregnancies at increased risk are possible if both pathogenic variants in a family have been identified.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="aoa.Diagnosis">
        <title>Diagnosis</title>
        <sec id="aoa.Suggestive_Findings">
          <title>Suggestive Findings</title>
          <p>Diagnosis of ataxia with oculomotor apraxia type 1 (AOA1) should be suspected in individuals with the following combination of clinical features and test results.</p>
          <p>
            <bold>Clinical features</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Cerebellar ataxia, oculomotor apraxia, and areflexia followed by signs of severe peripheral neuropathy</p>
            </list-item>
            <list-item>
              <p>Childhood onset</p>
            </list-item>
            <list-item>
              <p>Slow progression leading to severe motor handicap</p>
            </list-item>
            <list-item>
              <p>Long survival [<xref ref-type="bibr" rid="aoa.REF.barbot.2001.201">Barbot et al 2001</xref>]</p>
            </list-item>
            <list-item>
              <p>Absence of extraneurologic findings common in <related-object link-type="booklink" source-id="gene" document-id="ataxia-telangiectas" document-type="chapter">ataxia-telangiectasia</related-object> (telangiectasias and immunodeficiency).</p>
            </list-item>
            <list-item>
              <p>Family history consistent with autosomal recessive inheritance</p>
            </list-item>
          </list>
          <p>
            <bold>Test results</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p><bold>MRI.</bold> Cerebellar atrophy is present in all affected individuals. A very few individuals also have brain stem atrophy.</p>
            </list-item>
            <list-item>
              <p><bold>EMG.</bold> Signs of axonal neuropathy are found in 100% of individuals with AOA1. Note: Normal EMG results may be observed only in those investigated in the very early stages of the disease.</p>
            </list-item>
            <list-item>
              <p><bold>Laboratory findings</bold> that can be used to confirm the diagnosis of AOA1 in a symptomatic person include [<xref ref-type="bibr" rid="aoa.REF.barbot.2001.201">Barbot et al 2001</xref>, <xref ref-type="bibr" rid="aoa.REF.le_ber.2003.2761">Le Ber et al 2003</xref>]:</p>
              <list list-type="bullet">
                <list-item>
                  <p><bold>Serum concentration of albumin.</bold> Serum concentration of albumin is decreased (&#x0003c;3.8 g/L) in 83% of individuals with disease duration of more than ten to 15 years.</p>
                </list-item>
                <list-item>
                  <p><bold>Serum concentration of total cholesterol.</bold> Serum concentration of total cholesterol is increased (&#x0003e;5.6 mmol) in 68% of individuals with disease duration of more than ten to 15 years.</p>
                </list-item>
                <list-item>
                  <p>
                    <bold>Normal serum concentration of alpha-fetoprotein</bold>
                  </p>
                </list-item>
                <list-item>
                  <p><bold>Neuropathology.</bold> Nerve biopsy confirms axonal neuropathy.</p>
                </list-item>
              </list>
            </list-item>
          </list>
        </sec>
        <sec id="aoa.Establishing_the_Diagnosis">
          <title>Establishing the Diagnosis</title>
          <p>The diagnosis of AOA1 is established in a proband with the detection of biallelic pathogenic variants in <italic toggle="yes">APTX</italic> (see <xref ref-type="table" rid="aoa.T.summary_of_molecular_genetic_testi">Table 1</xref>).</p>
          <p><bold>One genetic testing strategy</bold> is sequence analysis of <italic toggle="yes">APTX.</italic> If only one or no pathogenic variant is found, perform deletion/duplication analysis.</p>
          <p><bold>An alternative genetic testing strategy</bold> is use of a multi-gene panel that includes <italic toggle="yes">APTX</italic> and other genes of interest (see <xref ref-type="sec" rid="aoa.Differential_Diagnosis">Differential Diagnosis</xref>). Note: The genes included and the methods used in multi-gene panels vary by laboratory and over time.</p>
          <table-wrap id="aoa.T.summary_of_molecular_genetic_testi" orientation="portrait" position="anchor">
            <label>Table 1. </label>
            <caption>
              <p>Summary of Molecular Genetic Testing Used in AOA1</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_aoa.T.summary_of_molecular_genetic_testi_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                  <th id="hd_h_aoa.T.summary_of_molecular_genetic_testi_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Test Method</th>
                  <th id="hd_h_aoa.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Proportion of Probands with a Pathogenic Variant Detectable by This Method</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_aoa.T.summary_of_molecular_genetic_testi_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                    <italic toggle="yes">APTX</italic>
                  </td>
                  <td headers="hd_h_aoa.T.summary_of_molecular_genetic_testi_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>2</sup></td>
                  <td headers="hd_h_aoa.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Unknown&#x000a0;<sup>3</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_aoa.T.summary_of_molecular_genetic_testi_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Deletion/duplication analysis&#x000a0;<sup>4</sup></td>
                  <td headers="hd_h_aoa.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Unknown&#x000a0;<sup>5</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_aoa.T.summary_of_molecular_genetic_testi_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Unknown&#x000a0;<sup>6</sup></td>
                  <td headers="hd_h_aoa.T.summary_of_molecular_genetic_testi_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">NA</td>
                  <td headers="hd_h_aoa.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="aoa.TF.1.1">
                <label>1. </label>
                <p>See <related-object source-id="gene" document-id="aoa" object-id="aoa.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein. See <xref ref-type="sec" rid="aoa.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants.</p>
              </fn>
              <fn id="aoa.TF.1.2">
                <label>2. </label>
                <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
              </fn>
              <fn id="aoa.TF.1.3">
                <label>3. </label>
                <p>All Portuguese families with AOA1 share the same pathogenic variant (<xref ref-type="table" rid="aoa.T.selected_aptx_variants">p.Trp279Ter</xref>), while Japanese families first described by <xref ref-type="bibr" rid="aoa.REF.uekawa.1992.1067">Uekawa et al [1992]</xref> shared another pathogenic variant (<xref ref-type="table" rid="aoa.T.selected_aptx_variants">c.689dupT</xref>).</p>
              </fn>
              <fn id="aoa.TF.1.4">
                <label>4. </label>
                <p>Testing that identifies exon or whole-gene deletions/duplications not detectable by sequence analysis of the coding and flanking intronic regions of genomic DNA. Included in the variety of methods that may be used are: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and chromosomal microarray (CMA) that includes this gene/chromosome segment.</p>
              </fn>
              <fn id="aoa.TF.1.5">
                <label>5. </label>
                <p>Deletion of the entire gene <italic toggle="yes">APTX</italic> has been reported [<xref ref-type="bibr" rid="aoa.REF.amouri.2004.928">Amouri et al 2004</xref>]. The frequency of alleles with partial- or whole-gene deletions is not known.</p>
              </fn>
              <fn id="aoa.TF.1.6">
                <label>6. </label>
                <p>Scanning for pathogenic variants identified variants diagnostic for either AOA1 or AOA2 in only 20 of the 43 (46.5%) individuals with the ataxia with oculomotor apraxia phenotype. In other words, almost half of Portuguese families with AOA do not appear to have AOA1 or AOA2 using scanning for pathogenic variants; thus, pathogenic variants in other genes or pathogenic variants not detectable by this test method (e.g., exon or whole-gene deletions) may be causative [<xref ref-type="bibr" rid="aoa.REF.bras.2015.474">Bras et al 2015</xref>].</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
      </sec>
      <sec id="aoa.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="aoa.Clinical_Description">
          <title>Clinical Description</title>
          <p>Ataxia is the main cause of disability in ataxia with oculomotor apraxia type 1 in the first stages of the disease. Later, peripheral axonal motor neuropathy dominates the clinical picture.</p>
          <p><bold>Cerebellar ataxia.</bold> Symptoms are first noticed between ages two and ten years (mean: 4.3 years). In about 50% of affected individuals, onset is before age seven years. Two Italian adults with cerebellar ataxia were reported having disease onset at ages 28 and 29 years [<xref ref-type="bibr" rid="aoa.REF.criscuolo.2004.2173">Criscuolo et al 2004</xref>].</p>
          <p>After initial normal motor development, all individuals develop cerebellar ataxia. The first manifestations of AOA1 are slowly progressive gait imbalance followed by dysarthria, then upper-limb dysmetria with mild intention tremor.</p>
          <p><bold>Oculomotor apraxia.</bold> Oculomotor apraxia is present in all individuals with AOA1. It is usually noticed a few years after the onset of ataxia. Oculomotor apraxia is the most striking feature in this disorder, but can be missed on routine neurologic examination. Individuals with oculomotor apraxia do not fixate normally on objects. When asked to look to one side, they turn their heads first, with eye contraversion, after which their eyes follow to the same side in several slow saccades with head thrusts.</p>
          <p>Blinking is exaggerated in most individuals.</p>
          <p>Ocular movements on command are usually slightly limited; the eyes stop before reaching extreme positions of gaze. These slow eye movements appear equally on lateral and vertical gaze.</p>
          <p>When the head is immobilized, movement of the eyes is impossible.</p>
          <p>Oculocephalic reflexes are spared until advanced stages of the disease. When standing and turning their heads, affected individuals lose their balance and tend to move the whole body to compensate.</p>
          <p>Ocular pursuit movements remain normal during the first years after the appearance of oculomotor apraxia. Later, oculomotor apraxia is followed by progressive external ophthalmoplegia (beginning with upward gaze).</p>
          <p><bold>Neuropathy.</bold> All individuals with AOA1 have an axonal peripheral neuropathy, with early areflexia that dominates the clinical picture in advanced phases of the disease and is the major cause of motor disability with severe weakness and wasting. Loss of independent walking happens about seven to ten years after onset; most individuals become wheelchair bound by adolescence.</p>
          <p>Hands and feet are short and atrophic. <italic toggle="yes">Pes cavus</italic> is present in 30% of individuals and scoliosis in a few.</p>
          <p>Vibration and postural sense are impaired only in older individuals with very long disease duration. Pain and light touch sensation are preserved.</p>
          <p><bold>Chorea.</bold> About 45% of affected individuals have chorea even after a long disease duration (&#x02264;51 years) [<xref ref-type="bibr" rid="aoa.REF.shimazaki.2002.590">Shimazaki et al 2002</xref>, <xref ref-type="bibr" rid="aoa.REF.le_ber.2003.2761">Le Ber et al 2003</xref>, <xref ref-type="bibr" rid="aoa.REF.sekijima.2003.1198">Sekijima et al 2003</xref>, <xref ref-type="bibr" rid="aoa.REF.tranchant.2003.868">Tranchant et al 2003</xref>, <xref ref-type="bibr" rid="aoa.REF.criscuolo.2004.2173">Criscuolo et al 2004</xref>, <xref ref-type="bibr" rid="aoa.REF.habeck.2004.591">Habeck et al 2004</xref>]. At onset, the percentage may be as high as 80%, but in almost 50% of affected individuals, chorea disappears over the course of the disease [<xref ref-type="bibr" rid="aoa.REF.le_ber.2003.2761">Le Ber et al 2003</xref>].</p>
          <p><bold>Dystonia.</bold> Upper-limb dystonia occurs in about 50% of individuals and may in some cases be sufficiently pronounced to justify diagnostic consideration of extrapyramidal disorders.</p>
          <p><bold>Intellect.</bold> Different degrees of cognitive impairment are observed, largely independent of ethnic origin [<xref ref-type="bibr" rid="aoa.REF.tachi.2000.82">Tachi et al 2000</xref>, <xref ref-type="bibr" rid="aoa.REF.moreira.2001a.501">Moreira et al 2001a</xref>, <xref ref-type="bibr" rid="aoa.REF.shimazaki.2002.590">Shimazaki et al 2002</xref>, <xref ref-type="bibr" rid="aoa.REF.le_ber.2003.2761">Le Ber et al 2003</xref>, <xref ref-type="bibr" rid="aoa.REF.sekijima.2003.1198">Sekijima et al 2003</xref>, <xref ref-type="bibr" rid="aoa.REF.criscuolo.2004.2173">Criscuolo et al 2004</xref>, <xref ref-type="bibr" rid="aoa.REF.quinzii.2005.539">Quinzii et al 2005</xref>]. Severe cognitive disability was reported in a single family [<xref ref-type="bibr" rid="aoa.REF.moreira.2001b.189">Moreira et al 2001b</xref>].</p>
          <p><bold>Life span.</bold> In the Portuguese kindreds, the age at last examination ranged from 17 to 68 years, corresponding to a disease duration of 12 to 58 years (mean: 27.5 years); two individuals died, one of an unknown cause and the other, a girl age 11 years with AOA1 who had been symptomatic for eight years, from a thalamic tumor. One Japanese individual died at age 71 years. In the cohort reported by <xref ref-type="bibr" rid="aoa.REF.le_ber.2003.2761">Le Ber et al [2003]</xref>, disease duration was 51 years.</p>
          <p><bold>Other.</bold> No signs of extraneurologic involvement are evident.</p>
        </sec>
        <sec id="aoa.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p><italic toggle="yes">APTX</italic> pathogenic missense variants may be associated with a later onset (age ~9 years). All other individuals with AOA1 with homozygous truncating variants (nonsense or frameshift) had onset ranging between ages two and 12 years (mean: 4.6 years) [<xref ref-type="bibr" rid="aoa.REF.moreira.2001b.189">Moreira et al 2001b</xref>, <xref ref-type="bibr" rid="aoa.REF.shimazaki.2002.590">Shimazaki et al 2002</xref>, <xref ref-type="bibr" rid="aoa.REF.le_ber.2003.2761">Le Ber et al 2003</xref>, <xref ref-type="bibr" rid="aoa.REF.sekijima.2003.1198">Sekijima et al 2003</xref>, <xref ref-type="bibr" rid="aoa.REF.amouri.2004.928">Amouri et al 2004</xref>, <xref ref-type="bibr" rid="aoa.REF.habeck.2004.591">Habeck et al 2004</xref>, <xref ref-type="bibr" rid="aoa.REF.quinzii.2005.539">Quinzii et al 2005</xref>].</p>
          <p>Cognitive impairment was reported in several families of different ethnic origins who had a range of variant types, including nonsense, frameshift, splice site, and missense [<xref ref-type="bibr" rid="aoa.REF.tachi.2000.82">Tachi et al 2000</xref>, <xref ref-type="bibr" rid="aoa.REF.barbot.2001.201">Barbot et al 2001</xref>, <xref ref-type="bibr" rid="aoa.REF.moreira.2001a.501">Moreira et al 2001a</xref>, <xref ref-type="bibr" rid="aoa.REF.shimazaki.2002.590">Shimazaki et al 2002</xref>, <xref ref-type="bibr" rid="aoa.REF.le_ber.2003.2761">Le Ber et al 2003</xref>, <xref ref-type="bibr" rid="aoa.REF.sekijima.2003.1198">Sekijima et al 2003</xref>, <xref ref-type="bibr" rid="aoa.REF.criscuolo.2004.2173">Criscuolo et al 2004</xref>, <xref ref-type="bibr" rid="aoa.REF.quinzii.2005.539">Quinzii et al 2005</xref>].</p>
          <list list-type="bullet">
            <list-item>
              <p>The <xref ref-type="table" rid="aoa.T.selected_aptx_variants">p.Trp279Ter</xref> nonsense variant can be associated with cognitive impairment [<xref ref-type="bibr" rid="aoa.REF.le_ber.2003.2761">Le Ber et al 2003</xref>] or normal cognitive development [<xref ref-type="bibr" rid="aoa.REF.moreira.2001a.501">Moreira et al 2001a</xref>, <xref ref-type="bibr" rid="aoa.REF.le_ber.2003.2761">Le Ber et al 2003</xref>, <xref ref-type="bibr" rid="aoa.REF.tranchant.2003.868">Tranchant et al 2003</xref>].</p>
            </list-item>
            <list-item>
              <p>The presence of severe cognitive impairment in <xref ref-type="table" rid="aoa.T.selected_aptx_variants">p.[Glu232GlyfsTer38]+[Pro206Leu]</xref> compound heterozygotes and the presence of mild cognitive impairment/borderline intelligence in the respective homozygotes is unexplained.</p>
            </list-item>
          </list>
          <p>Two compound heterozygotes for the <xref ref-type="table" rid="aoa.T.selected_aptx_variants">p.Arg199His</xref> missense variant and an unidentified second pathogenic variant had an atypical presentation with marked dystonia and mask-like faces in addition to the AOA1 clinical picture.</p>
          <p>The pathogenic variant <xref ref-type="table" rid="aoa.T.selected_aptx_variants">p.Ala198Val</xref> is associated with predominant, more severe and persistent chorea [<xref ref-type="bibr" rid="aoa.REF.le_ber.2003.2761">Le Ber et al 2003</xref>].</p>
          <p>In two Italian adults, homozygous <xref ref-type="table" rid="aoa.T.selected_aptx_variants">p.Pro206Leu</xref> and <xref ref-type="table" rid="aoa.T.selected_aptx_variants">p.His201Gln</xref> pathogenic variants were associated with late-onset AOA1 (ages 28 and 29 years). In contrast, in Japanese individuals with AOA1, the <xref ref-type="table" rid="aoa.T.selected_aptx_variants">p.Pro206Leu</xref> pathogenic variant is associated with earlier onset (age 10 years).</p>
          <p>The pathogenic missense variant <xref ref-type="table" rid="aoa.T.selected_aptx_variants">p.Pro206Leu</xref> is associated with a later onset [<xref ref-type="bibr" rid="aoa.REF.date.2001.184">Date et al 2001</xref>] and the pathogenic variants <xref ref-type="table" rid="aoa.T.selected_aptx_variants">p.Val263Gly</xref> and <xref ref-type="table" rid="aoa.T.selected_aptx_variants">p.Lys197Gln</xref> with even later onset: age 15 years [<xref ref-type="bibr" rid="aoa.REF.tranchant.2003.868">Tranchant et al 2003</xref>] and 25 years [<xref ref-type="bibr" rid="aoa.REF.date.2001.184">Date et al 2001</xref>] respectively.</p>
          <p>To the authors' knowledge, no correlation exists between a specific pathogenic variant and the affected individual's survival.</p>
        </sec>
        <sec id="aoa.Nomenclature">
          <title>Nomenclature</title>
          <p>In Japan, AOA1 is called early-onset ataxia with oculomotor apraxia and hypoalbuminemia [<xref ref-type="bibr" rid="aoa.REF.date.2001.184">Date et al 2001</xref>, <xref ref-type="bibr" rid="aoa.REF.shimazaki.2002.590">Shimazaki et al 2002</xref>, <xref ref-type="bibr" rid="aoa.REF.sekijima.2003.1198">Sekijima et al 2003</xref>].</p>
        </sec>
        <sec id="aoa.Prevalence">
          <title>Prevalence</title>
          <p>Through a systematic population-based survey of hereditary ataxias being conducted in Portugal since 1993 [<xref ref-type="bibr" rid="aoa.REF.silva.1997.1377">Silva et al 1997</xref>], <related-object link-type="booklink" source-id="gene" document-id="friedreich" document-type="chapter">Friedreich ataxia</related-object> (as expected) was found to be the most frequent autosomal recessive ataxia (32.8%), followed by AOA (12.6%). In Portugal there are now 42 individuals with AOA in 20 different families (AOA1= 3.6% of all autosomal recessive ataxias; AOA2= 3.3%). AOA prevalence in Portugal is estimated at 0.41 per 100,000 inhabitants. However, 20 of these individuals with AOA from 13 different families do not have either AOA1 or AOA2, illustrating AOA genetic heterogeneity [<xref ref-type="bibr" rid="aoa.REF.bras.2015.474">Bras et al 2015</xref>].</p>
          <p>In Japan, AOA1 appears to be the most frequent cause of autosomal recessive ataxia [<xref ref-type="bibr" rid="aoa.REF.uekawa.1992.1067">Uekawa et al 1992</xref>, <xref ref-type="bibr" rid="aoa.REF.fukuhara.1995.140">Fukuhara et al 1995</xref>, <xref ref-type="bibr" rid="aoa.REF.hanihara.1995.83">Hanihara et al 1995</xref>, <xref ref-type="bibr" rid="aoa.REF.kubota.1995.289">Kubota et al 1995</xref>, <xref ref-type="bibr" rid="aoa.REF.sekijima.1998.30">Sekijima et al 1998</xref>, <xref ref-type="bibr" rid="aoa.REF.tachi.2000.82">Tachi et al 2000</xref>, <xref ref-type="bibr" rid="aoa.REF.moreira.2001a.501">Moreira et al 2001a</xref>, <xref ref-type="bibr" rid="aoa.REF.shimazaki.2002.590">Shimazaki et al 2002</xref>, <xref ref-type="bibr" rid="aoa.REF.sekijima.2003.1198">Sekijima et al 2003</xref>]. In the entire cohort studied by <xref ref-type="bibr" rid="aoa.REF.le_ber.2003.2761">Le Ber et al [2003]</xref> mostly individuals of French origin with progressive cerebellar ataxia in whom Friedreich ataxia had been excluded &#x02014; the frequency of AOA1 was 5.7%; among the subset of individuals with onset before age 25 years, the frequency of AOA1 was 9.1%.</p>
          <p>Affected individuals with pathogenic variants in <italic toggle="yes">APTX</italic> have been identified worldwide: thirteen individuals from three unrelated Tunisian families [<xref ref-type="bibr" rid="aoa.REF.amouri.2004.928">Amouri et al 2004</xref>]; two unrelated individuals from Germany [<xref ref-type="bibr" rid="aoa.REF.habeck.2004.591">Habeck et al 2004</xref>]; three unrelated Italian individuals [<xref ref-type="bibr" rid="aoa.REF.criscuolo.2004.2173">Criscuolo et al 2004</xref>]; two American children [<xref ref-type="bibr" rid="aoa.REF.tsao.2005.619">Tsao &#x00026; Paulson 2005</xref>]; and four individuals of northern European heritage with ataxia and CoQ<sub>10</sub> deficiency [<xref ref-type="bibr" rid="aoa.REF.quinzii.2005.539">Quinzii et al 2005</xref>].</p>
        </sec>
      </sec>
      <sec id="aoa.Genetically_Related_Allelic_Disorder">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>No phenotypes other than those discussed in this <italic toggle="yes">GeneReview</italic> are known to be associated with mutation of <italic toggle="yes">APTX</italic>.</p>
      </sec>
      <sec id="aoa.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The diagnosis of AOA1 is ruled out whenever the clinical picture includes non-progressive ataxia, microcephaly, or seizures. The differential diagnosis varies by age group.</p>
        <p><related-object link-type="booklink" source-id="gene" document-id="aoa2" document-type="chapter"><bold>Ataxia with oculomotor apraxia type 2</bold></related-object>
<bold>(AOA2)</bold>, the disorder most likely to be confused with AOA1, is characterized by onset between age three and 30 years, cerebellar atrophy, axonal sensorimotor neuropathy, oculomotor apraxia, and elevated serum concentration of alpha-fetoprotein (AFP). See <xref ref-type="table" rid="aoa.T.comparison_of_aoa1_aoa2_aoa3_and_a">Table 2</xref>.</p>
        <p>AOA2 is associated with pathogenic variants of <italic toggle="yes">SETX</italic>, the gene that encodes the protein senataxin [<xref ref-type="bibr" rid="aoa.REF.moreira.2004.225">Moreira et al 2004</xref>]. In one study, AOA2 accounted for 8% of all autosomal recessive cerebellar ataxia, making it second only to Friedreich ataxia in prevalence among adults with autosomal recessive ataxia [<xref ref-type="bibr" rid="aoa.REF.le_ber.2004.759">Le Ber et al 2004</xref>].</p>
        <p><bold>Ataxia with oculomotor apraxia type 3 (AOA3)</bold> (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/615217">615217</ext-link>) was described in a Saudi family in association with a pathogenic missense variant in <italic toggle="yes">PIK3R5</italic>. The disorder is most likely to be clinically and biochemically confused with AOA2 [<xref ref-type="bibr" rid="aoa.REF.al_tassan.2012.351">Al Tassan et al 2012</xref>].</p>
        <p><bold>Ataxia with oculomotor apraxia type 4 (AOA4)</bold> was recently described in a cohort of nine Portuguese families associated with pathogenic variants in <italic toggle="yes">PNKP</italic>. Age of onset and clinical presentation, with marked extrapyramidal manifestations and rapid progression resembles AOA1 except for cognitive impairment. AOA4 is the most frequent form of AOA in the Portuguese population [<xref ref-type="bibr" rid="aoa.REF.bras.2015.474">Bras et al 2015</xref>].</p>
        <table-wrap id="aoa.T.comparison_of_aoa1_aoa2_aoa3_and_a" orientation="portrait" position="anchor">
          <label>Table 2. </label>
          <caption>
            <p>Comparison of AOA1, AOA2, AOA3 and AOA4</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_aoa.T.comparison_of_aoa1_aoa2_aoa3_and_a_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">AOA Type</th>
                <th id="hd_h_aoa.T.comparison_of_aoa1_aoa2_aoa3_and_a_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">AOA1</th>
                <th id="hd_h_aoa.T.comparison_of_aoa1_aoa2_aoa3_and_a_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">AOA2</th>
                <th id="hd_h_aoa.T.comparison_of_aoa1_aoa2_aoa3_and_a_1_1_1_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">AOA3</th>
                <th id="hd_h_aoa.T.comparison_of_aoa1_aoa2_aoa3_and_a_1_1_1_5" valign="middle" align="left" scope="col" rowspan="1" colspan="1">AOA4</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_aoa.T.comparison_of_aoa1_aoa2_aoa3_and_a_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <bold>Mean age at onset (range)</bold>
                </td>
                <td headers="hd_h_aoa.T.comparison_of_aoa1_aoa2_aoa3_and_a_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">4.3 years (2-10)</td>
                <td headers="hd_h_aoa.T.comparison_of_aoa1_aoa2_aoa3_and_a_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">13 years (10-14)</td>
                <td headers="hd_h_aoa.T.comparison_of_aoa1_aoa2_aoa3_and_a_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">15.6 years (14-18)</td>
                <td headers="hd_h_aoa.T.comparison_of_aoa1_aoa2_aoa3_and_a_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">4.3 years (1-9)</td>
              </tr>
              <tr>
                <td headers="hd_h_aoa.T.comparison_of_aoa1_aoa2_aoa3_and_a_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <bold>Evolution</bold>
                </td>
                <td headers="hd_h_aoa.T.comparison_of_aoa1_aoa2_aoa3_and_a_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">More severe</td>
                <td headers="hd_h_aoa.T.comparison_of_aoa1_aoa2_aoa3_and_a_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">More benign</td>
                <td headers="hd_h_aoa.T.comparison_of_aoa1_aoa2_aoa3_and_a_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">More benign</td>
                <td headers="hd_h_aoa.T.comparison_of_aoa1_aoa2_aoa3_and_a_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">More severe</td>
              </tr>
              <tr>
                <td headers="hd_h_aoa.T.comparison_of_aoa1_aoa2_aoa3_and_a_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <bold>Oculomotor apraxia</bold>
                </td>
                <td headers="hd_h_aoa.T.comparison_of_aoa1_aoa2_aoa3_and_a_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Early and severe</td>
                <td headers="hd_h_aoa.T.comparison_of_aoa1_aoa2_aoa3_and_a_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Mild to moderate</td>
                <td headers="hd_h_aoa.T.comparison_of_aoa1_aoa2_aoa3_and_a_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Late and severe</td>
                <td headers="hd_h_aoa.T.comparison_of_aoa1_aoa2_aoa3_and_a_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">Early and severe</td>
              </tr>
              <tr>
                <td headers="hd_h_aoa.T.comparison_of_aoa1_aoa2_aoa3_and_a_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <bold>Dystonia</bold>
                </td>
                <td headers="hd_h_aoa.T.comparison_of_aoa1_aoa2_aoa3_and_a_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Marked, early in the disease, disappearing with age</td>
                <td headers="hd_h_aoa.T.comparison_of_aoa1_aoa2_aoa3_and_a_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Less marked</td>
                <td headers="hd_h_aoa.T.comparison_of_aoa1_aoa2_aoa3_and_a_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Not mentioned</td>
                <td headers="hd_h_aoa.T.comparison_of_aoa1_aoa2_aoa3_and_a_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">Marked, early in the disease,</td>
              </tr>
              <tr>
                <td headers="hd_h_aoa.T.comparison_of_aoa1_aoa2_aoa3_and_a_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <bold>Neuropathy</bold>
                </td>
                <td headers="hd_h_aoa.T.comparison_of_aoa1_aoa2_aoa3_and_a_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Early and severe</td>
                <td headers="hd_h_aoa.T.comparison_of_aoa1_aoa2_aoa3_and_a_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Less severe and beginning later in the disease</td>
                <td headers="hd_h_aoa.T.comparison_of_aoa1_aoa2_aoa3_and_a_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Severe</td>
                <td headers="hd_h_aoa.T.comparison_of_aoa1_aoa2_aoa3_and_a_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">Early and severe</td>
              </tr>
              <tr>
                <td headers="hd_h_aoa.T.comparison_of_aoa1_aoa2_aoa3_and_a_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <bold>Cognitive impairment</bold>
                </td>
                <td headers="hd_h_aoa.T.comparison_of_aoa1_aoa2_aoa3_and_a_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Not present</td>
                <td headers="hd_h_aoa.T.comparison_of_aoa1_aoa2_aoa3_and_a_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Not present</td>
                <td headers="hd_h_aoa.T.comparison_of_aoa1_aoa2_aoa3_and_a_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Not mentioned</td>
                <td headers="hd_h_aoa.T.comparison_of_aoa1_aoa2_aoa3_and_a_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">Often present</td>
              </tr>
              <tr>
                <td headers="hd_h_aoa.T.comparison_of_aoa1_aoa2_aoa3_and_a_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <bold>Biochemical findings</bold>
                </td>
                <td headers="hd_h_aoa.T.comparison_of_aoa1_aoa2_aoa3_and_a_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Late-onset low serum albumin and high cholesterol; normal alpha-fetoprotein at all stages</td>
                <td headers="hd_h_aoa.T.comparison_of_aoa1_aoa2_aoa3_and_a_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Early elevation of alpha-fetoprotein</td>
                <td headers="hd_h_aoa.T.comparison_of_aoa1_aoa2_aoa3_and_a_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Early elevation of alpha-fetoprotein</td>
                <td headers="hd_h_aoa.T.comparison_of_aoa1_aoa2_aoa3_and_a_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">Variable levels of serum albumin, cholesterol,and alpha-fetoprotein</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
        <p><bold>Early childhood.</bold> The diagnosis of AOA1 can be difficult to establish in very young children because all features of the disorder are not yet apparent.</p>
        <list list-type="bullet">
          <list-item>
            <p>When oculomotor apraxia is present, <related-object link-type="booklink" source-id="gene" document-id="ataxia-telangiectas" document-type="chapter">ataxia-telangiectasia</related-object> can be excluded.</p>
          </list-item>
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="joubert" document-type="chapter">Joubert syndrome</related-object> is a rare, autosomal recessive disorder that affects the cerebellum and brain stem. It is characterized by the presence of a distinct respiratory pattern and profound tachypnea in the newborn period. Nonspecific features such as hypotonia, ataxia, developmental delay, and oculomotor apraxia can occur. The diagnosis of Joubert syndrome is based on the presence of these characteristic clinical features and is confirmed with cranial magnetic resonance imaging (MRI), which reveals the "molar tooth sign" resulting from hypoplasia of the cerebellar vermis and accompanying brain stem abnormalities [<xref ref-type="bibr" rid="aoa.REF.maria.1999.583">Maria et al 1999</xref>, <xref ref-type="bibr" rid="aoa.REF.merritt.2003.178">Merritt 2003</xref>].</p>
          </list-item>
        </list>
        <p>
          <bold>Adolescence</bold>
        </p>
        <list list-type="bullet">
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="friedreich" document-type="chapter">Friedreich ataxia</related-object> (FRDA) can be excluded on clinical grounds. In FRDA, oculomotor apraxia is not observed and the cerebellum is normal on MRI. Molecular genetic testing of <italic toggle="yes">FRDA</italic> detects pathogenic variants in almost 100% of affected individuals.</p>
          </list-item>
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="aved" document-type="chapter">Ataxia with vitamin E deficiency</related-object> (AVED) and <related-object link-type="booklink" source-id="gene" document-id="coq10-def" document-type="chapter">coenzyme Q<sub>10</sub> deficiency</related-object> should be considered because they are treatable disorders [<xref ref-type="bibr" rid="aoa.REF.musumeci.2001.849">Musumeci et al 2001</xref>, <xref ref-type="bibr" rid="aoa.REF.quinzii.2005.539">Quinzii et al 2005</xref>].</p>
          </list-item>
          <list-item>
            <p>Peripheral neuropathy with areflexia and <italic toggle="yes">pes cavus</italic> may be confused with Charcot-Marie-Tooth syndrome. See <related-object link-type="booklink" source-id="gene" document-id="cmt" document-type="chapter">Charcot-Marie-Tooth Hereditary Neuropathy Overview</related-object>.</p>
          </list-item>
        </list>
        <p><bold>Adulthood.</bold> In apparent simplex cases (individuals with no family history of AOA1), <related-object link-type="booklink" source-id="gene" document-id="sca2" document-type="chapter">SCA2</related-object>, which also associates cerebellar ataxia with slow eye movements, can be excluded by molecular genetic testing of <italic toggle="yes">ATXN2,</italic> the gene in which mutation causes SCA2 [<xref ref-type="bibr" rid="aoa.REF.pulst.1996.269">Pulst et al 1996</xref>].</p>
        <p>See also <related-object link-type="booklink" source-id="gene" document-id="ataxias" document-type="chapter">Ataxia Overview</related-object>.</p>
      </sec>
      <sec id="aoa.Management">
        <title>Management</title>
        <sec id="aoa.Evaluations_Following_Initial_Diagno">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs in an individual diagnosed with ataxia with oculomotor apraxia type 1 (AOA1), the following evaluations are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>Examination of cognitive function</p>
            </list-item>
            <list-item>
              <p>Examination of cranial nerve function</p>
            </list-item>
            <list-item>
              <p>Extended neurologic examination of the limbs: initial inspection, tone, strength testing, reflexes, coordination, sensory testing</p>
            </list-item>
            <list-item>
              <p>Ophthalmologic examination</p>
            </list-item>
            <list-item>
              <p>Clinical genetics consultation</p>
            </list-item>
          </list>
        </sec>
        <sec id="aoa.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>Physical therapy may be helpful, particularly for disabilities resulting from peripheral neuropathy.</p>
          <p>A wheelchair is usually necessary for mobility by age 15-20 years.</p>
          <p>Educational support should be provided to compensate for difficulties in speaking (dysarthria), in reading (oculomotor apraxia), and in writing (upper-limb ataxia and weakness).</p>
        </sec>
        <sec id="aoa.Prevention_of_Secondary_Complication">
          <title>Prevention of Secondary Complications</title>
          <p>High-protein diet to restore serum albumin concentration is indicated to prevent edema secondary to hypoalbuminemia.</p>
          <p>Low-cholesterol diet is advised.</p>
        </sec>
        <sec id="aoa.Surveillance">
          <title>Surveillance</title>
          <p>Routine visits to the neurologist are appropriate.</p>
        </sec>
        <sec id="aoa.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>See <xref ref-type="sec" rid="aoa.Related_Genetic_Counseling_Issues">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="aoa.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p>
        </sec>
      </sec>
      <sec id="aoa.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="aoa.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>AOA1 is inherited in an autosomal recessive manner.</p>
        </sec>
        <sec id="aoa.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Both parents of an affected indiviudal are obligate heterozygotes (i.e., carriers of one <italic toggle="yes">APTX</italic> pathogenic variant).</p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier.</p>
            </list-item>
            <list-item>
              <p>Once an at-risk sib is known to be unaffected, the risk of his/her being a carrier of an <italic toggle="yes">APTX</italic> pathogenic variant is 2/3.</p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> All the offspring of an individual with AOA1 are obligate heterozygotes (carriers) for a pathogenic variant in <italic toggle="yes">APTX</italic>.</p>
          <p><bold>Other family members.</bold> Each sib of the proband's parents is at a 50% risk of being a carrier of an <italic toggle="yes">APTX</italic> pathogenic variant.</p>
        </sec>
        <sec id="aoa.Carrier_Detection">
          <title>Carrier Detection</title>
          <p>Carrier testing for at-risk family members is possible if the pathogenic variants in the family have been identified.</p>
        </sec>
        <sec id="aoa.Related_Genetic_Counseling_Issues">
          <title>Related Genetic Counseling Issues</title>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk, clarification of carrier status, and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected, are carriers, or are at risk of being carriers.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="aoa.Prenatal_Testing">
          <title>Prenatal Testing</title>
          <p>If the <italic toggle="yes">APTX</italic> pathogenic variants have been identified in an affected family member, prenatal testing for pregnancies at increased risk may be available from a clinical laboratory that offers either testing of this gene or custom prenatal testing.</p>
          <p><bold>Preimplantation genetic diagnosis (PGD)</bold> may be an option for some families in which the pathogenic variants have been identified.</p>
        </sec>
      </sec>
      <sec id="aoa.Resources">
        <title>Resources</title>
      </sec>
      <sec id="aoa.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <sec id="aoa.Molecular_Genetic_Pathogenesis">
          <title>Molecular Genetic Pathogenesis</title>
          <p><italic toggle="yes">APTX</italic> is the only gene known to be associated with AOA1 [<xref ref-type="bibr" rid="aoa.REF.date.2001.184">Date et al 2001</xref>, <xref ref-type="bibr" rid="aoa.REF.moreira.2001b.189">Moreira et al 2001b</xref>]. It encodes the protein aprataxin, which plays a role in DNA-single-strand break repair [<xref ref-type="bibr" rid="aoa.REF.hirano.2007.162">Hirano et al 2007</xref>] and double-strand break repair machinery [<xref ref-type="bibr" rid="aoa.REF.clements.2004.1493">Clements et al 2004</xref>].</p>
          <p><bold>Gene structure.</bold>
<italic toggle="yes">APTX</italic> consists of seven exons. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="aoa" object-id="aoa.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
          <p><bold>Benign variants</bold> have been reported (see <xref ref-type="table" rid="aoa.T.selected_aptx_variants">Table 3</xref>).</p>
          <p><bold>Pathogenic variants.</bold> To date, 16 different pathogenic variants have been found in 37 families from different countries on three continents (<xref ref-type="table" rid="aoa.T.selected_aptx_variants">Table 3</xref>).</p>
          <table-wrap id="aoa.T.selected_aptx_variants" orientation="portrait" position="anchor">
            <label>Table 3. </label>
            <caption>
              <p>Selected <italic toggle="yes">APTX</italic> Variants</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_aoa.T.selected_aptx_variants_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Variant Classification</th>
                  <th id="hd_h_aoa.T.selected_aptx_variants_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Exon / Intron</th>
                  <th id="hd_h_aoa.T.selected_aptx_variants_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change <break/>(Alias&#x000a0;<sup>1</sup>)</th>
                  <th id="hd_h_aoa.T.selected_aptx_variants_1_1_1_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change&#x000a0;<sup>2</sup></th>
                  <th id="hd_h_aoa.T.selected_aptx_variants_1_1_1_5" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Effect on Aprataxin</th>
                  <th id="hd_h_aoa.T.selected_aptx_variants_1_1_1_6" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_aoa.T.selected_aptx_variants_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                    <bold>Benign</bold>
                  </td>
                  <td headers="hd_h_aoa.T.selected_aptx_variants_1_1_1_2" valign="top" align="left" rowspan="1" colspan="1">Intron 1</td>
                  <td headers="hd_h_aoa.T.selected_aptx_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">c.134-12A&#x0003e;C</td>
                  <td headers="hd_h_aoa.T.selected_aptx_variants_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">---</td>
                  <td headers="hd_h_aoa.T.selected_aptx_variants_1_1_1_5" rowspan="2" valign="middle" align="left" colspan="1">None</td>
                  <td headers="hd_h_aoa.T.selected_aptx_variants_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">--</td>
                </tr>
                <tr>
                  <td headers="hd_h_aoa.T.selected_aptx_variants_1_1_1_2" valign="top" colspan="1" align="left" scope="row" rowspan="1">Exon 3</td>
                  <td headers="hd_h_aoa.T.selected_aptx_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">c.431C&#x0003e;A</td>
                  <td headers="hd_h_aoa.T.selected_aptx_variants_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">p.Ser144Tyr</td>
                  <td headers="hd_h_aoa.T.selected_aptx_variants_1_1_1_6" valign="middle" colspan="1" align="left" rowspan="1">--</td>
                </tr>
                <tr>
                  <td headers="hd_h_aoa.T.selected_aptx_variants_1_1_1_1" rowspan="16" valign="middle" align="left" scope="row" colspan="1">
                    <bold>Pathogenic</bold>
                  </td>
                  <td headers="hd_h_aoa.T.selected_aptx_variants_1_1_1_2" rowspan="9" valign="middle" align="left" colspan="1">Exon 5</td>
                  <td headers="hd_h_aoa.T.selected_aptx_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">c.589A&#x0003e;C</td>
                  <td headers="hd_h_aoa.T.selected_aptx_variants_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">p.Lys197Gln</td>
                  <td headers="hd_h_aoa.T.selected_aptx_variants_1_1_1_5" rowspan="6" valign="middle" align="left" colspan="1">Missense; aberrant processing</td>
                  <td headers="hd_h_aoa.T.selected_aptx_variants_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">
                    <xref ref-type="bibr" rid="aoa.REF.tranchant.2003.868">Tranchant et al [2003]</xref>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_aoa.T.selected_aptx_variants_1_1_1_3" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.593C&#x0003e;T</td>
                  <td headers="hd_h_aoa.T.selected_aptx_variants_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">p.Ala198Val</td>
                  <td headers="hd_h_aoa.T.selected_aptx_variants_1_1_1_6" valign="middle" colspan="1" align="left" rowspan="1"><xref ref-type="bibr" rid="aoa.REF.le_ber.2003.2761">Le Ber et al [2003]</xref>, <xref ref-type="bibr" rid="aoa.REF.criscuolo.2004.2173">Criscuolo et al [2004]</xref></td>
                </tr>
                <tr>
                  <td headers="hd_h_aoa.T.selected_aptx_variants_1_1_1_3" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.596G&#x0003e;A</td>
                  <td headers="hd_h_aoa.T.selected_aptx_variants_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">p.Arg199His</td>
                  <td headers="hd_h_aoa.T.selected_aptx_variants_1_1_1_6" valign="middle" colspan="1" align="left" rowspan="1">
                    <xref ref-type="bibr" rid="aoa.REF.moreira.2001b.189">Moreira et al [2001b]</xref>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_aoa.T.selected_aptx_variants_1_1_1_3" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.602A&#x0003e;G</td>
                  <td headers="hd_h_aoa.T.selected_aptx_variants_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">p.His201Arg</td>
                  <td headers="hd_h_aoa.T.selected_aptx_variants_1_1_1_6" valign="middle" colspan="1" align="left" rowspan="1">
                    <xref ref-type="bibr" rid="aoa.REF.shimazaki.2002.590">Shimazaki et al [2002]</xref>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_aoa.T.selected_aptx_variants_1_1_1_3" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.603T&#x0003e;A</td>
                  <td headers="hd_h_aoa.T.selected_aptx_variants_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">p.His201Gln</td>
                  <td headers="hd_h_aoa.T.selected_aptx_variants_1_1_1_6" valign="middle" colspan="1" align="left" rowspan="1">
                    <xref ref-type="bibr" rid="aoa.REF.criscuolo.2004.2173">Criscuolo et al [2004]</xref>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_aoa.T.selected_aptx_variants_1_1_1_3" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.617C&#x0003e;T</td>
                  <td headers="hd_h_aoa.T.selected_aptx_variants_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">p.Pro206Leu</td>
                  <td headers="hd_h_aoa.T.selected_aptx_variants_1_1_1_6" valign="middle" colspan="1" align="left" rowspan="1"><xref ref-type="bibr" rid="aoa.REF.date.2001.184">Date et al [2001]</xref>, <xref ref-type="bibr" rid="aoa.REF.moreira.2001b.189">Moreira et al [2001b]</xref>, <xref ref-type="bibr" rid="aoa.REF.shimazaki.2002.590">Shimazaki et al [2002]</xref>, <xref ref-type="bibr" rid="aoa.REF.criscuolo.2004.2173">Criscuolo et al [2004]</xref></td>
                </tr>
                <tr>
                  <td headers="hd_h_aoa.T.selected_aptx_variants_1_1_1_3" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.689dupT<break/>(689insT)<break/>(689-690insT)</td>
                  <td headers="hd_h_aoa.T.selected_aptx_variants_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">p.Glu232GlyfsTer38</td>
                  <td headers="hd_h_aoa.T.selected_aptx_variants_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">Frameshift; truncation</td>
                  <td headers="hd_h_aoa.T.selected_aptx_variants_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="aoa.REF.date.2001.184">Date et al [2001]</xref>, <xref ref-type="bibr" rid="aoa.REF.moreira.2001b.189">Moreira et al [2001b]</xref>, <xref ref-type="bibr" rid="aoa.REF.shimazaki.2002.590">Shimazaki et al [2002]</xref>, <xref ref-type="bibr" rid="aoa.REF.sekijima.2003.1198">Sekijima et al [2003]</xref></td>
                </tr>
                <tr>
                  <td headers="hd_h_aoa.T.selected_aptx_variants_1_1_1_3" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.739 C&#x0003e;T</td>
                  <td headers="hd_h_aoa.T.selected_aptx_variants_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">p.Arg247Ter</td>
                  <td headers="hd_h_aoa.T.selected_aptx_variants_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">Stop; truncation</td>
                  <td headers="hd_h_aoa.T.selected_aptx_variants_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">
                    <xref ref-type="bibr" rid="aoa.REF.mosesso.2005.485">Mosesso et al [2005]</xref>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_aoa.T.selected_aptx_variants_1_1_1_3" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.770+1G&#x0003e;A</td>
                  <td headers="hd_h_aoa.T.selected_aptx_variants_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">--</td>
                  <td headers="hd_h_aoa.T.selected_aptx_variants_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">Splice; truncation</td>
                  <td headers="hd_h_aoa.T.selected_aptx_variants_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">
                    <xref ref-type="bibr" rid="aoa.REF.le_ber.2003.2761">Le Ber et al [2003]</xref>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_aoa.T.selected_aptx_variants_1_1_1_2" rowspan="5" valign="middle" colspan="1" align="left" scope="row">Exon 6</td>
                  <td headers="hd_h_aoa.T.selected_aptx_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">c.788T&#x0003e;G</td>
                  <td headers="hd_h_aoa.T.selected_aptx_variants_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">p.Val263Gly</td>
                  <td headers="hd_h_aoa.T.selected_aptx_variants_1_1_1_5" rowspan="3" valign="middle" align="left" colspan="1">Missense; aberrant processing</td>
                  <td headers="hd_h_aoa.T.selected_aptx_variants_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">
                    <xref ref-type="bibr" rid="aoa.REF.date.2001.184">Date et al [2001]</xref>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_aoa.T.selected_aptx_variants_1_1_1_3" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.800A&#x0003e;G</td>
                  <td headers="hd_h_aoa.T.selected_aptx_variants_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">p.Asp267Gly</td>
                  <td headers="hd_h_aoa.T.selected_aptx_variants_1_1_1_6" rowspan="2" valign="middle" colspan="1" align="left">
                    <xref ref-type="bibr" rid="aoa.REF.le_ber.2003.2761">Le Ber et al [2003]</xref>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_aoa.T.selected_aptx_variants_1_1_1_3" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.835T&#x0003e;C</td>
                  <td headers="hd_h_aoa.T.selected_aptx_variants_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">p.Trp279Arg</td>
                </tr>
                <tr>
                  <td headers="hd_h_aoa.T.selected_aptx_variants_1_1_1_3" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.837G&#x0003e;A</td>
                  <td headers="hd_h_aoa.T.selected_aptx_variants_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">p.Trp279Ter</td>
                  <td headers="hd_h_aoa.T.selected_aptx_variants_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">Stop; truncation</td>
                  <td headers="hd_h_aoa.T.selected_aptx_variants_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="aoa.REF.moreira.2001b.189">Moreira et al [2001b]</xref>, <xref ref-type="bibr" rid="aoa.REF.le_ber.2003.2761">Le Ber et al [2003]</xref>, <xref ref-type="bibr" rid="aoa.REF.tranchant.2003.868">Tranchant et al [2003]</xref>, <xref ref-type="bibr" rid="aoa.REF.habeck.2004.591">Habeck et al [2004]</xref>, <xref ref-type="bibr" rid="aoa.REF.quinzii.2005.539">Quinzii et al [2005]</xref></td>
                </tr>
                <tr>
                  <td headers="hd_h_aoa.T.selected_aptx_variants_1_1_1_3" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.841delT</td>
                  <td headers="hd_h_aoa.T.selected_aptx_variants_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">p.Ser281LeufsTer8</td>
                  <td headers="hd_h_aoa.T.selected_aptx_variants_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">Frameshift; truncation</td>
                  <td headers="hd_h_aoa.T.selected_aptx_variants_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">
                    <xref ref-type="bibr" rid="aoa.REF.date.2001.184">Date et al [2001]</xref>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_aoa.T.selected_aptx_variants_1_1_1_2" rowspan="2" valign="middle" colspan="1" align="left" scope="row">Exon 7</td>
                  <td headers="hd_h_aoa.T.selected_aptx_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">c.875-1G&#x0003e;A</td>
                  <td headers="hd_h_aoa.T.selected_aptx_variants_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">--</td>
                  <td headers="hd_h_aoa.T.selected_aptx_variants_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">Splice; truncation</td>
                  <td headers="hd_h_aoa.T.selected_aptx_variants_1_1_1_6" rowspan="2" valign="middle" align="left" colspan="1">
                    <xref ref-type="bibr" rid="aoa.REF.amouri.2004.928">Amouri et al [2004]</xref>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_aoa.T.selected_aptx_variants_1_1_1_3" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Total deletion of gene</td>
                  <td headers="hd_h_aoa.T.selected_aptx_variants_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">--</td>
                  <td headers="hd_h_aoa.T.selected_aptx_variants_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">No product</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn>
                <p>Note on variant classification: Variants listed in the table have been provided by the authors. GeneReviews staff have not independently verified the classification of variants.</p>
              </fn>
              <fn>
                <p>Note on nomenclature: GeneReviews follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
              </fn>
              <fn id="aoa.TF.3.1">
                <label>1. </label>
                <p>Variant designation that does not conform to current naming conventions</p>
              </fn>
              <fn id="aoa.TF.3.2">
                <label>2. </label>
                <p>Reference sequences are those of the long isoform: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/28329436">NP_778243.1</ext-link> and <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/28329435">NM_175073.1</ext-link></p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p><bold>Normal gene product.</bold>
<italic toggle="yes">APTX</italic> encodes a ubiquitously expressed protein, aprataxin. Alternative splicing on exon 3 generates two distinct isoforms. The longer transcript (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/28329435">NM_175073.1</ext-link>) is the major form found in human cell lines, with the shorter, frame-shifted form being present in lower amount [<xref ref-type="bibr" rid="aoa.REF.date.2001.184">Date et al 2001</xref>, <xref ref-type="bibr" rid="aoa.REF.moreira.2001b.189">Moreira et al 2001b</xref>]. The longer transcript codes for a 342-amino acid protein (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/28329436">NP_778243.1</ext-link>), while the shorter one encodes a 168-amino acid protein. The longer transcript is composed of three domains:</p>
          <list list-type="bullet">
            <list-item>
              <p>The PANT domain (PNKP-AOA1 N-terminal domain), also known as putative forkhead-associated (FHA) domain [<xref ref-type="bibr" rid="aoa.REF.caldecott.2003.7">Caldecott 2003</xref>] corresponding to the N-terminal region of aprataxin that shares 41% identity only with the N-terminus of animal polynucleotide kinase 3' phosphatase (PNKP) [<xref ref-type="bibr" rid="aoa.REF.jilani.1999.24176">Jilani et al 1999</xref>, <xref ref-type="bibr" rid="aoa.REF.karimibusheri.1999.24187">Karimi-Busheri et al 1999</xref>, <xref ref-type="bibr" rid="aoa.REF.moreira.2001b.189">Moreira et al 2001b</xref>]. This domain facilitates binding to phosphorylated proteins [<xref ref-type="bibr" rid="aoa.REF.kijas.2006.13939">Kijas et al 2006</xref>]. The PNKP (dual 5' kinase 3' phosphatase) interacts with DNA polymerase b, DNA ligase III, and XRCC1 protein, forming the single-strand break repair (SSBR) complex, following exposure to ionizing radiation and reactive oxygen species [<xref ref-type="bibr" rid="aoa.REF.whitehouse.2001.107">Whitehouse et al 2001</xref>].</p>
            </list-item>
            <list-item>
              <p>The HIT domain (middle domain), defined by the HIT motif, for nucleotide binding and hydrolysis. Members of the HIT super family (histidine triad) of nucleotide hydrolases/transferases [<xref ref-type="bibr" rid="aoa.REF.brenner.2002.9003">Brenner 2002</xref>] can be divided into two main groups:</p>
              <list list-type="bullet">
                <list-item>
                  <p>The Hint (histidine triad nucleotide binding)-related proteins, binding nucleotides and displaying adenosine 5'-monophosphoramidase activity [<xref ref-type="bibr" rid="aoa.REF.brenner.1997.231">Brenner et al 1997</xref>]</p>
                </list-item>
                <list-item>
                  <p>The Fhit (fragile histidine triad)-related proteins, cleaving diadenosine tetraphosphate (Ap<sub>4</sub>A), which is potentially produced during activation of the SSBR complex [<xref ref-type="bibr" rid="aoa.REF.mclennan.2000.73">McLennan 2000</xref>]</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>The C-terminal domain, containing a divergent zinc-finger motif [<xref ref-type="bibr" rid="aoa.REF.moreira.2001b.189">Moreira et al 2001b</xref>], which could allow binding to DNA and/or RNA [<xref ref-type="bibr" rid="aoa.REF.kijas.2006.13939">Kijas et al 2006</xref>]</p>
            </list-item>
          </list>
          <p>The presence of these three domains has suggested that aprataxin is a nuclear protein with a role in DNA repair, reminiscent of the function of the protein defective in <related-object link-type="booklink" source-id="gene" document-id="ataxia-telangiectas" document-type="chapter">ataxia-telangiectasia</related-object>, which would cause a phenotype restricted to neurologic signs when mutated. Subcellular localization studies showed that aprataxin is a nuclear protein, present in both the nucleoplasm and the nucleolus [<xref ref-type="bibr" rid="aoa.REF.gueven.2004.1081">Gueven et al 2004</xref>, <xref ref-type="bibr" rid="aoa.REF.sano.2004.241">Sano et al 2004</xref>]. Recent experimental studies indicate that aprataxin has dual DNA binding and nucleotide hydrolase activities. Aprataxin binds to double-stranded DNA with high affinity but is also capable of binding to double-stranded RNA and to single-stranded DNA, with increased affinity for hairpin structures. Aprataxin also hydrolyses, with similar efficiency, the model histidine triad nucleotide-binding protein substrate (AMPNH<sub>2</sub>) and the fragile histidine triad protein substrate (Ap<sub>4</sub>A) [<xref ref-type="bibr" rid="aoa.REF.kijas.2006.13939">Kijas et al 2006</xref>].</p>
          <p>Several in vitro and in vivo studies have shown that aprataxin (long isoform) interacts with <italic toggle="yes">XRCC1</italic> [<xref ref-type="bibr" rid="aoa.REF.caldecott.2003.7">Caldecott 2003</xref>, <xref ref-type="bibr" rid="aoa.REF.clements.2004.1493">Clements et al 2004</xref>, <xref ref-type="bibr" rid="aoa.REF.gueven.2004.1081">Gueven et al 2004</xref>, <xref ref-type="bibr" rid="aoa.REF.sano.2004.241">Sano et al 2004</xref>] and <italic toggle="yes">XRCC4</italic> [<xref ref-type="bibr" rid="aoa.REF.clements.2004.1493">Clements et al 2004</xref>], proteins implicated in single-strand and double-strand repair mechanisms, respectively. The interaction with C-terminal region of <italic toggle="yes">XRCC1</italic> is made through the 20 N-terminal amino acids of aprataxin FHA domain [<xref ref-type="bibr" rid="aoa.REF.date.2004.1279">Date et al 2004</xref>]. This interaction is important in maintaining the steady-state protein level of <italic toggle="yes">XRCC1</italic> [<xref ref-type="bibr" rid="aoa.REF.luo.2004.8356">Luo et al 2004</xref>]. Interaction with another single-strand break repair protein, PARP-1, was also reported [<xref ref-type="bibr" rid="aoa.REF.date.2004.1279">Date et al 2004</xref>].</p>
          <p><bold>Abnormal gene product.</bold>
<xref ref-type="bibr" rid="aoa.REF.gueven.2004.1081">Gueven et al [2004]</xref> demonstrated that pathogenic variants (even missense ones) in <italic toggle="yes">APTX</italic> destabilize aprataxin and that cells from individuals with AOA1 are characterized by enhanced sensitivity to agents that cause single-strand breaks in DNA; however, no gross defect in single-strand break repair is apparent, even though the long isoform of aprataxin interacts with XRCC1 [<xref ref-type="bibr" rid="aoa.REF.caldecott.2003.7">Caldecott 2003</xref>, <xref ref-type="bibr" rid="aoa.REF.clements.2004.1493">Clements et al 2004</xref>, <xref ref-type="bibr" rid="aoa.REF.gueven.2004.1081">Gueven et al 2004</xref>, <xref ref-type="bibr" rid="aoa.REF.sano.2004.241">Sano et al 2004</xref>].</p>
          <p>Even when in vitro and in vivo studies show that aprataxin interacts with XRCC4, AOA1 cell lines exhibit neither radio-resistant DNA synthesis nor a reduced ability to phosphorylate downstream targets of ATM following DNA damage, suggesting that AOA1 lacks the cell cycle checkpoint defects that are characteristic of ataxia-telangiectasia [<xref ref-type="bibr" rid="aoa.REF.clements.2004.1493">Clements et al 2004</xref>]. Recently, cells of an individual with AOA1 homozygous for a stop variant showed marked, dose-related increases in induced chromosomal aberrations but did not show hypersensitivity to ionizing radiation, indicating direct involvement of aprataxin in the DNA single-strand break repair mechanisms [<xref ref-type="bibr" rid="aoa.REF.mosesso.2005.485">Mosesso et al 2005</xref>].</p>
        </sec>
      </sec>
      <sec id="aoa.References">
        <title>References</title>
        <sec id="aoa.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="aoa.Literature_Cited.reflist0">
            <ref id="aoa.REF.al_tassan.2012.351">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Al Tassan</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Khalil</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shinwari</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al Sharif</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bavi</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abduljaleel</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abu Dhaim</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Magrashi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bobis</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ahmed</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alahmed</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bohlega</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>A missense mutation in <italic toggle="yes">PIK3R5</italic> gene in a family with ataxia and oculomotor apraxia.</article-title>
                <source>Hum Mutat</source>
                <volume>33</volume>
                <fpage>351</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">22065524</pub-id>
              </element-citation>
            </ref>
            <ref id="aoa.REF.amouri.2004.928">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Amouri</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moreira</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zouari</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>El Euch</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barhoumi</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kefi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Belal</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koenig</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hentati</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Aprataxin gene mutations in Tunisian families.</article-title>
                <source>Neurology</source>
                <volume>63</volume>
                <fpage>928</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">15365154</pub-id>
              </element-citation>
            </ref>
            <ref id="aoa.REF.barbot.2001.201">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Barbot</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coutinho</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chorao</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferreira</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barros</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fineza</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dias</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Monteiro</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guimaraes</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mendonca</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>do Ceu Moreira</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sequeiros</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Recessive ataxia with ocular apraxia: review of 22 Portuguese patients.</article-title>
                <source>Arch Neurol</source>
                <volume>58</volume>
                <fpage>201</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">11176957</pub-id>
              </element-citation>
            </ref>
            <ref id="aoa.REF.bras.2015.474">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bras</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alonso</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barbot</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Costa</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Darwent</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Orme</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sequeiros</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hardy</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coutinho</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guerreiro</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <article-title>Mutations in PNKP cause recessive ataxia with oculomotor apraxia type 4.</article-title>
                <source>Am J Hum Genet.</source>
                <year>2015</year>
                <volume>96</volume>
                <fpage>474</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">25728773</pub-id>
              </element-citation>
            </ref>
            <ref id="aoa.REF.brenner.2002.9003">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Brenner</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Hint, Fhit, and GalT: function, structure, evolution, and mechanism of three branches of the histidine triad superfamily of nucleotide hydrolases and transferases.</article-title>
                <source>Biochemistry</source>
                <volume>41</volume>
                <fpage>9003</fpage>
                <lpage>14</lpage>
                <pub-id pub-id-type="pmid">12119013</pub-id>
              </element-citation>
            </ref>
            <ref id="aoa.REF.brenner.1997.231">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Brenner</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garrison</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gilmour</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peisach</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ringe</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Petsko</surname>
                    <given-names>GA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lowenstein</surname>
                    <given-names>JM</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>Crystal structures of HINT demonstrate that histidine triad proteins are GalT-related nucleotide-binding proteins.</article-title>
                <source>Nat Struct Biol</source>
                <volume>4</volume>
                <fpage>231</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">9164465</pub-id>
              </element-citation>
            </ref>
            <ref id="aoa.REF.caldecott.2003.7">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Caldecott</surname>
                    <given-names>KW</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>DNA single-strand break repair and spinocerebellar ataxia.</article-title>
                <source>Cell</source>
                <volume>112</volume>
                <fpage>7</fpage>
                <lpage>10</lpage>
                <pub-id pub-id-type="pmid">12526788</pub-id>
              </element-citation>
            </ref>
            <ref id="aoa.REF.clements.2004.1493">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Clements</surname>
                    <given-names>PM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Breslin</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Deeks</surname>
                    <given-names>ED</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Byrd</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ju</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bieganowski</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brenner</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moreira</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taylor</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Caldecott</surname>
                    <given-names>KW</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>The ataxia-oculomotor apraxia 1 gene product has a role distinct from ATM and interacts with the DNA strand break repair proteins XRCC1 and XRCC4.</article-title>
                <source>DNA Repair (Amst)</source>
                <volume>3</volume>
                <fpage>1493</fpage>
                <lpage>502</lpage>
                <pub-id pub-id-type="pmid">15380105</pub-id>
              </element-citation>
            </ref>
            <ref id="aoa.REF.criscuolo.2004.2173">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Criscuolo</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mancini</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sacca</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Michele</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Monticelli</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Santoro</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scarano</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Banfi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Filla</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Ataxia with oculomotor apraxia type 1 in Southern Italy: late onset and variable phenotype.</article-title>
                <source>Neurology</source>
                <volume>63</volume>
                <fpage>2173</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">15596775</pub-id>
              </element-citation>
            </ref>
            <ref id="aoa.REF.date.2004.1279">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Date</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Igarashi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sano</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takahashi</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takahashi</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takano</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsuji</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nishizawa</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Onodera</surname>
                    <given-names>O</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>The FHA domain of aprataxin interacts with the C-terminal region of XRCC1.</article-title>
                <source>Biochem Biophys Res Commun</source>
                <volume>325</volume>
                <fpage>1279</fpage>
                <lpage>85</lpage>
                <pub-id pub-id-type="pmid">15555565</pub-id>
              </element-citation>
            </ref>
            <ref id="aoa.REF.date.2001.184">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Date</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Onodera</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tanaka</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iwabuchi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uekawa</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Igarashi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koike</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hiroi</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yuasa</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Awaya</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sakai</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takahashi</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nagatomo</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sekijima</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kawachi</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takiyama</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nishizawa</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fukuhara</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saito</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sugano</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsuji</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Early-onset ataxia with ocular motor apraxia and hypoalbuminemia is caused by mutations in a new HIT superfamily gene.</article-title>
                <source>Nat Genet</source>
                <volume>29</volume>
                <fpage>184</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">11586299</pub-id>
              </element-citation>
            </ref>
            <ref id="aoa.REF.fukuhara.1995.140">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fukuhara</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakajima</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sakajiri</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matsubara</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fujita</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>1995</year>
                <article-title>Hereditary motor and sensory neuropathy associated with cerebellar atrophy (HMSNCA): a new disease.</article-title>
                <source>J Neurol Sci</source>
                <volume>133</volume>
                <fpage>140</fpage>
                <lpage>51</lpage>
                <pub-id pub-id-type="pmid">8583217</pub-id>
              </element-citation>
            </ref>
            <ref id="aoa.REF.gueven.2004.1081">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gueven</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Becherel</surname>
                    <given-names>OJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kijas</surname>
                    <given-names>AW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Howe</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rudolph</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gatti</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Date</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Onodera</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taucher-Scholz</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lavin</surname>
                    <given-names>MF</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Aprataxin, a novel protein that protects against genotoxic stress.</article-title>
                <source>Hum Mol Genet</source>
                <volume>13</volume>
                <fpage>1081</fpage>
                <lpage>93</lpage>
                <pub-id pub-id-type="pmid">15044383</pub-id>
              </element-citation>
            </ref>
            <ref id="aoa.REF.habeck.2004.591">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Habeck</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zuhlke</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bentele</surname>
                    <given-names>KH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Unkelbach</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kress</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burk</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwinger</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hellenbroich</surname>
                    <given-names>Y</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Aprataxin mutations are a rare cause of early onset ataxia in Germany.</article-title>
                <source>J Neurol</source>
                <volume>251</volume>
                <fpage>591</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">15164193</pub-id>
              </element-citation>
            </ref>
            <ref id="aoa.REF.hanihara.1995.83">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hanihara</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kubota</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Amano</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iwamoto</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iwabuchi</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>1995</year>
                <article-title>Siblings of early onset cerebellar ataxia with hypoalbuminemia.</article-title>
                <source>Rinsho Shinkeigaku</source>
                <volume>35</volume>
                <fpage>83</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">7781224</pub-id>
              </element-citation>
            </ref>
            <ref id="aoa.REF.hirano.2007.162">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hirano</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamamoto</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mori</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lan</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iwamoto</surname>
                    <given-names>TA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aoki</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shimada</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Furiya</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kariya</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Asai</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yasui</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nishiwaki</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Imoto</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kobayashi</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kiriyama</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nagata</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Konishi</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Itoyama</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ueno</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>DNA single-strand break repair is impaired in aprataxin-related ataxia.</article-title>
                <source>Ann Neurol</source>
                <volume>61</volume>
                <fpage>162</fpage>
                <lpage>74</lpage>
                <pub-id pub-id-type="pmid">17315206</pub-id>
              </element-citation>
            </ref>
            <ref id="aoa.REF.jilani.1999.24176">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jilani</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ramotar</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Slack</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ong</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>XM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scherer</surname>
                    <given-names>SW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lasko</surname>
                    <given-names>DD</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Molecular cloning of the human gene, PNKP, encoding a polynucleotide kinase 3'-phosphatase and evidence for its role in repair of DNA strand breaks caused by oxidative damage.</article-title>
                <source>J Biol Chem</source>
                <volume>274</volume>
                <fpage>24176</fpage>
                <lpage>86</lpage>
                <pub-id pub-id-type="pmid">10446192</pub-id>
              </element-citation>
            </ref>
            <ref id="aoa.REF.karimibusheri.1999.24187">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Karimi-Busheri</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Daly</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robins</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Canas</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pappin</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sgouros</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miller</surname>
                    <given-names>GG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fakhrai</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davis</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Le Beau</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weinfeld</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Molecular characterization of a human DNA kinase.</article-title>
                <source>J Biol Chem</source>
                <volume>274</volume>
                <fpage>24187</fpage>
                <lpage>94</lpage>
                <pub-id pub-id-type="pmid">10446193</pub-id>
              </element-citation>
            </ref>
            <ref id="aoa.REF.kijas.2006.13939">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kijas</surname>
                    <given-names>AW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harris</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harris</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lavin</surname>
                    <given-names>MF</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Aprataxin Forms a Discrete Branch in the HIT (Histidine Triad) Superfamily of Proteins with Both DNA/RNA Binding and Nucleotide Hydrolase Activities.</article-title>
                <source>J Biol Chem</source>
                <volume>281</volume>
                <fpage>13939</fpage>
                <lpage>48</lpage>
                <pub-id pub-id-type="pmid">16547001</pub-id>
              </element-citation>
            </ref>
            <ref id="aoa.REF.kubota.1995.289">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kubota</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sunohara</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iwabuchi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hanihara</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nagatomo</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Amano</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kosaka</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>1995</year>
                <article-title>Familial early onset cerebellar ataxia with hypoalbuminemia.</article-title>
                <source>No To Shinkei</source>
                <volume>47</volume>
                <fpage>289</fpage>
                <lpage>94</lpage>
                <pub-id pub-id-type="pmid">7669433</pub-id>
              </element-citation>
            </ref>
            <ref id="aoa.REF.le_ber.2004.759">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Le Ber</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bouslam</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rivaud-Pechoux</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guimaraes</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benomar</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chamayou</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goizet</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moreira</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klur</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yahyaoui</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Agid</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koenig</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stevanin</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brice</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Durr</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Frequency and phenotypic spectrum of ataxia with oculomotor apraxia 2: a clinical and genetic study in 18 patients.</article-title>
                <source>Brain</source>
                <volume>127</volume>
                <fpage>759</fpage>
                <lpage>67</lpage>
                <pub-id pub-id-type="pmid">14736755</pub-id>
              </element-citation>
            </ref>
            <ref id="aoa.REF.le_ber.2003.2761">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Le Ber</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moreira</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rivaud-Pechoux</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chamayou</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ochsner</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuntzer</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tardieu</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Said</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Habert</surname>
                    <given-names>MO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Demarquay</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tannier</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beis</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brice</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koenig</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Durr</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Cerebellar ataxia with oculomotor apraxia type 1: clinical and genetic studies.</article-title>
                <source>Brain</source>
                <volume>126</volume>
                <fpage>2761</fpage>
                <lpage>72</lpage>
                <pub-id pub-id-type="pmid">14506070</pub-id>
              </element-citation>
            </ref>
            <ref id="aoa.REF.luo.2004.8356">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Luo</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chan</surname>
                    <given-names>DW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rodriguez</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>BP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leng</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mu</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Songyang</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Qin</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>A new XRCC1-containing complex and its role in cellular survival of methyl methanesulfonate treatment.</article-title>
                <source>Mol Cell Biol</source>
                <volume>24</volume>
                <fpage>8356</fpage>
                <lpage>65</lpage>
                <pub-id pub-id-type="pmid">15367657</pub-id>
              </element-citation>
            </ref>
            <ref id="aoa.REF.maria.1999.583">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Maria</surname>
                    <given-names>BL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boltshauser</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Palmer</surname>
                    <given-names>SC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tran</surname>
                    <given-names>TX</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Clinical features and revised diagnostic criteria in Joubert syndrome.</article-title>
                <source>J Child Neurol</source>
                <volume>14</volume>
                <fpage>583</fpage>
                <lpage>90</lpage>
                <pub-id pub-id-type="pmid">10488903</pub-id>
              </element-citation>
            </ref>
            <ref id="aoa.REF.mclennan.2000.73">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>McLennan</surname>
                    <given-names>AG</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Dinucleoside polyphosphates-friend or foe?</article-title>
                <source>Pharmacol Ther</source>
                <volume>87</volume>
                <fpage>73</fpage>
                <lpage>89</lpage>
                <pub-id pub-id-type="pmid">11007992</pub-id>
              </element-citation>
            </ref>
            <ref id="aoa.REF.merritt.2003.178">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Merritt</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Recognition of the clinical signs and symptoms of Joubert syndrome.</article-title>
                <source>Adv Neonatal Care</source>
                <volume>3</volume>
                <fpage>178</fpage>
                <lpage>86</lpage>
                <pub-id pub-id-type="pmid">14502525</pub-id>
              </element-citation>
            </ref>
            <ref id="aoa.REF.moreira.2001a.501">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Moreira</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barbot</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tachi</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kozuka</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mendonca</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barros</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coutinho</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sequeiros</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koenig</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2001a</year>
                <article-title>Homozygosity mapping of Portuguese and Japanese forms of ataxia-oculomotor apraxia to 9p13, and evidence for genetic heterogeneity.</article-title>
                <source>Am J Hum Genet</source>
                <volume>68</volume>
                <fpage>501</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">11170899</pub-id>
              </element-citation>
            </ref>
            <ref id="aoa.REF.moreira.2001b.189">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Moreira</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barbot</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tachi</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kozuka</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uchida</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gibson</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mendonca</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Costa</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barros</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yanagisawa</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Watanabe</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ikeda</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aoki</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nagata</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coutinho</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sequeiros</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koenig</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2001b</year>
                <article-title>The gene mutated in ataxia-ocular apraxia 1 encodes the new HIT/Zn- finger protein aprataxin.</article-title>
                <source>Nat Genet</source>
                <volume>29</volume>
                <fpage>189</fpage>
                <lpage>93</lpage>
                <pub-id pub-id-type="pmid">11586300</pub-id>
              </element-citation>
            </ref>
            <ref id="aoa.REF.moreira.2004.225">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Moreira</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klur</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Watanabe</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nemeth</surname>
                    <given-names>AH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Le Ber</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moniz</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tranchant</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aubourg</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tazir</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schols</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pandolfo</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schulz</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pouget</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Calvas</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shizuka-Ikeda</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shoji</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tanaka</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Izatt</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shaw</surname>
                    <given-names>CE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>M'Zahem</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dunne</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bomont</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benhassine</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bouslam</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stevanin</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brice</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guimaraes</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mendonca</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barbot</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coutinho</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sequeiros</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Durr</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Warter</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koenig</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Senataxin, the ortholog of a yeast RNA helicase, is mutant in ataxia-ocular apraxia 2.</article-title>
                <source>Nat Genet</source>
                <volume>36</volume>
                <fpage>225</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">14770181</pub-id>
              </element-citation>
            </ref>
            <ref id="aoa.REF.mosesso.2005.485">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mosesso</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Piane</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Palitti</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pepe</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Penna</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chessa</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>The novel human gene aprataxin is directly involved in DNA single-strand-break repair.</article-title>
                <source>Cell Mol Life Sci</source>
                <volume>62</volume>
                <fpage>485</fpage>
                <lpage>91</lpage>
                <pub-id pub-id-type="pmid">15719174</pub-id>
              </element-citation>
            </ref>
            <ref id="aoa.REF.musumeci.2001.849">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Musumeci</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Naini</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Slonim</surname>
                    <given-names>AE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Skavin</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hadjigeorgiou</surname>
                    <given-names>GL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krawiecki</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weissman</surname>
                    <given-names>BM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsao</surname>
                    <given-names>CY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mendell</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shanske</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Vivo</surname>
                    <given-names>DC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hirano</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DiMauro</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Familial cerebellar ataxia with muscle coenzyme Q10 deficiency.</article-title>
                <source>Neurology</source>
                <volume>56</volume>
                <fpage>849</fpage>
                <lpage>55</lpage>
                <pub-id pub-id-type="pmid">11294920</pub-id>
              </element-citation>
            </ref>
            <ref id="aoa.REF.pulst.1996.269">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pulst</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nechiporuk</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nechiporuk</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gispert</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>XN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lopes-Cendes</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pearlman</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Starkman</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Orozco-Diaz</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lunkes</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DeJong</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rouleau</surname>
                    <given-names>GA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Auburger</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Korenberg</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Figueroa</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sahba</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>1996</year>
                <article-title>Moderate expansion of a normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2.</article-title>
                <source>Nat Genet</source>
                <volume>14</volume>
                <fpage>269</fpage>
                <lpage>76</lpage>
                <pub-id pub-id-type="pmid">8896555</pub-id>
              </element-citation>
            </ref>
            <ref id="aoa.REF.quinzii.2005.539">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Quinzii</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kattah</surname>
                    <given-names>AG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Naini</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Akman</surname>
                    <given-names>HO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mootha</surname>
                    <given-names>VK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DiMauro</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hirano</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Coenzyme Q deficiency and cerebellar ataxia associated with an aprataxin mutation.</article-title>
                <source>Neurology</source>
                <volume>64</volume>
                <fpage>539</fpage>
                <lpage>41</lpage>
                <pub-id pub-id-type="pmid">15699391</pub-id>
              </element-citation>
            </ref>
            <ref id="aoa.REF.sano.2004.241">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sano</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Date</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Igarashi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Onodera</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oyake</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takahashi</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hayashi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morimatsu</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takahashi</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Makifuchi</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fukuhara</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsuji</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Aprataxin, the causative protein for EAOH is a nuclear protein with a potential role as a DNA repair protein.</article-title>
                <source>Ann Neurol</source>
                <volume>55</volume>
                <fpage>241</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">14755728</pub-id>
              </element-citation>
            </ref>
            <ref id="aoa.REF.sekijima.2003.1198">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sekijima</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hashimoto</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Onodera</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Date</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Okano</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Naito</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsuji</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ikeda</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Severe generalized dystonia as a presentation of a patient with aprataxin gene mutation.</article-title>
                <source>Mov Disord</source>
                <volume>18</volume>
                <fpage>1198</fpage>
                <lpage>200</lpage>
                <pub-id pub-id-type="pmid">14534929</pub-id>
              </element-citation>
            </ref>
            <ref id="aoa.REF.sekijima.1998.30">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sekijima</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ohara</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakagawa</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tabata</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yoshida</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ishigame</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shimizu</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yanagisawa</surname>
                    <given-names>N</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Hereditary motor and sensory neuropathy associated with cerebellar atrophy (HMSNCA): clinical and neuropathological features of a Japanese family.</article-title>
                <source>J Neurol Sci</source>
                <volume>158</volume>
                <fpage>30</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">9667774</pub-id>
              </element-citation>
            </ref>
            <ref id="aoa.REF.shimazaki.2002.590">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Shimazaki</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takiyama</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sakoe</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ikeguchi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Niijima</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaneko</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Namekawa</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ogawa</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Date</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsuji</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakano</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nishizawa</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Early-onset ataxia with ocular motor apraxia and hypoalbuminemia: the aprataxin gene mutations.</article-title>
                <source>Neurology</source>
                <volume>59</volume>
                <fpage>590</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">12196655</pub-id>
              </element-citation>
            </ref>
            <ref id="aoa.REF.silva.1997.1377">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Silva</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coutinho</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pinheiro</surname>
                    <given-names>CD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neves</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Serrano</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>Hereditary ataxias and spastic paraplegias: methodological aspects of a prevalence study in Portugal.</article-title>
                <source>J Clin Epidemiol</source>
                <volume>50</volume>
                <fpage>1377</fpage>
                <lpage>84</lpage>
                <pub-id pub-id-type="pmid">9449941</pub-id>
              </element-citation>
            </ref>
            <ref id="aoa.REF.tachi.2000.82">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tachi</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kozuka</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ohya</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chiba</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sasaki</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Hereditary cerebellar ataxia with peripheral neuropathy and mental retardation.</article-title>
                <source>Eur Neurol</source>
                <volume>43</volume>
                <fpage>82</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">10686465</pub-id>
              </element-citation>
            </ref>
            <ref id="aoa.REF.tranchant.2003.868">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tranchant</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fleury</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moreira</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koenig</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Warter</surname>
                    <given-names>JM</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Phenotypic variability of aprataxin gene mutations.</article-title>
                <source>Neurology</source>
                <volume>60</volume>
                <fpage>868</fpage>
                <lpage>70</lpage>
                <pub-id pub-id-type="pmid">12629250</pub-id>
              </element-citation>
            </ref>
            <ref id="aoa.REF.tsao.2005.619">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tsao</surname>
                    <given-names>CY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Paulson</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Type 1 ataxia with oculomotor apraxia with aprataxin gene mutations in two American children.</article-title>
                <source>J Child Neurol</source>
                <volume>20</volume>
                <fpage>619</fpage>
                <lpage>20</lpage>
                <pub-id pub-id-type="pmid">16159533</pub-id>
              </element-citation>
            </ref>
            <ref id="aoa.REF.uekawa.1992.1067">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Uekawa</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yuasa</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kawasaki</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Makibuchi</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ideta</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>1992</year>
                <article-title>A hereditary ataxia associated with hypoalbuminemia and hyperlipidemia--a variant form of Friedreich's disease or a new clinical entity?</article-title>
                <source>Rinsho Shinkeigaku</source>
                <volume>32</volume>
                <fpage>1067</fpage>
                <lpage>74</lpage>
                <pub-id pub-id-type="pmid">1297549</pub-id>
              </element-citation>
            </ref>
            <ref id="aoa.REF.whitehouse.2001.107">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Whitehouse</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taylor</surname>
                    <given-names>RM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thistlethwaite</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karimi-Busheri</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lasko</surname>
                    <given-names>DD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weinfeld</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Caldecott</surname>
                    <given-names>KW</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>XRCC1 stimulates human polynucleotide kinase activity at damaged DNA termini and accelerates DNA single-strand break repair.</article-title>
                <source>Cell</source>
                <volume>104</volume>
                <fpage>107</fpage>
                <lpage>17</lpage>
                <pub-id pub-id-type="pmid">11163244</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
        <sec id="aoa.Suggested_Reading">
          <title>Suggested Reading</title>
          <ref-list id="aoa.Suggested_Reading.reflist0">
            <ref id="aoa.REF.le_ber.2005.411">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Le Ber</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brice</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Durr</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>New autosomal recessive cerebellar ataxias with oculomotor apraxia.</article-title>
                <source>Curr Neurol Neurosci Rep</source>
                <volume>5</volume>
                <fpage>411</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">16131425</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="aoa.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="aoa.Acknowledgments">
          <title>Acknowledgments</title>
          <p>The authors wish to express their gratitude to all patients and families for their collaboration and support, as well as to all the physicians involved in the clinical study of the families. Genetic studies were supported by funds from the Funda&#x000e7;&#x000e3;o para a Ci&#x000ea;ncia e a Tecnologia (Portuguese Ministry of Science) and the Portuguese Ministry of Health (projects STRDA/C/SAU/277/92, PECS/C/SAU/219/95, POCI/SAU-ESP/59114/04).</p>
        </sec>
        <sec id="aoa.Author_History">
          <title>Author History</title>
          <p>Paula Coutinho, MD, PhD (2002-present)Clara Barbot MD, PhD (2002-present)Maria-C&#x000e9;u Moreira da Silva, MS, PhD; CNRS/INSERM/Universit&#x000e9; Louis-Pasteur (2002-2010)Michel Koenig, MD, PhD; CNRS/INSERM/Universit&#x000e9; Louis-Pasteur (2002-2010)</p>
        </sec>
        <sec id="aoa.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>19 March 2015 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>22 June 2010 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>5 June 2006 (me) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>25 May 2004 (me) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>28 January 2004 (pc) Revision: change in test availability</p>
            </list-item>
            <list-item>
              <p>11 June 2002 (me) Review posted to live Web site</p>
            </list-item>
            <list-item>
              <p>8 November 2001 (pc) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
